Correlation Between Verve Therapeutics and Repligen
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Repligen, you can compare the effects of market volatilities on Verve Therapeutics and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Repligen.
Diversification Opportunities for Verve Therapeutics and Repligen
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Verve and Repligen is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Repligen go up and down completely randomly.
Pair Corralation between Verve Therapeutics and Repligen
Given the investment horizon of 90 days Verve Therapeutics is expected to generate 1.35 times more return on investment than Repligen. However, Verve Therapeutics is 1.35 times more volatile than Repligen. It trades about 0.04 of its potential returns per unit of risk. Repligen is currently generating about 0.02 per unit of risk. If you would invest 525.00 in Verve Therapeutics on August 30, 2024 and sell it today you would earn a total of 53.00 from holding Verve Therapeutics or generate 10.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verve Therapeutics vs. Repligen
Performance |
| Timeline |
| Verve Therapeutics |
| Repligen |
Verve Therapeutics and Repligen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verve Therapeutics and Repligen
The main advantage of trading using opposite Verve Therapeutics and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
| Repligen vs. Verve Therapeutics | Repligen vs. Beam Therapeutics | Repligen vs. Caribou Biosciences | Repligen vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |